MosaiQ AiPlex CD
Commercial- Indications
- Celiac disease
Company intelligence / Profile preview
AliveDx is a commercial-stage global in vitro diagnostics company with over 30 years of experience. Its proprietary MosaiQ® multiplexed microarray platform and the new LumiQ™ immunofluorescence assay automate complex laboratory workflows to deliver rapid, accurate results for autoimmune disease and allergy diagnostics. The Alba reagent portfolio supports safe blood transfusions worldwide. AliveDx’s solutions are CE-marked/FDA-cleared where applicable and are used globally to improve lab efficiency and patient care[1][2][3][4].
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AliveDx.